The predictive value of PD-L1 in response to PD-1/PD-L1 antibodies across various tumor types is still uncertain, and the interpretation of PD-L1 expression in tumors continues to be a subject of debate, requiring a comprehensive understanding. Here, CD274 is linked to neoplasm.